Description
BSE announces changes to the Short Term Additional Surveillance Measure (ST-ASM) framework with 12 securities being added, 5 securities moving out, and updated consolidated list effective February 04, 2026.
Summary
BSE has announced changes to the Short Term Additional Surveillance Measure (ST-ASM) framework effective February 04, 2026. The circular includes three annexures: Annexure I lists 12 securities being shortlisted in the ST-ASM framework, Annexure II lists 5 securities moving out of the framework, and Annexure III provides a consolidated list of all securities currently under ST-ASM with their respective stages (Stage I or Stage II).
Key Points
- 12 securities shortlisted in Short Term 5/15/30 Days ASM Framework effective February 04, 2026
- 5 securities moving out of ST-ASM Framework effective February 04, 2026
- No securities moving to higher or lower ASM stages within the framework
- Framework includes both main board and SME securities
- Securities are categorized into Stage I and Stage II surveillance measures
- Consolidated list includes 9 securities actively under ST-ASM surveillance
Securities Added to ST-ASM (Annexure I)
Stage I Securities:
- AJC Jewel Manufacturers Ltd (544425) - SME scrip
- Alfa Transformers Ltd (517546)
- Biofil Chemicals & Pharmaceuticals Ltd (524396)
- Biogen Pharmachem Industries Ltd (531752)
- Rainbow Foundations Ltd (531694)
- Sahara Maritime Ltd (544056) - SME scrip
- Sharda Cropchem Ltd (538666)
- Silverline Technologies Ltd (500389)
- T T Ltd (514142)
- Trans Freight Containers Ltd (513063)
- United Foodbrands Ltd (543283)
- Wanbury Ltd (524212)
Securities Moving Out of ST-ASM (Annexure II)
- AI Champdany Industries Ltd (532806)
- Bharat Rasayan Ltd (590021)
- Dhampur Bio Organics Ltd (543593)
- Oasis Securities Ltd (512489)
- Oval Projects Engineering Ltd (544498) - SME scrip
Consolidated Active List (Partial - Annexure III)
Stage I:
- AJC Jewel Manufacturers Ltd (SME)
- Alfa Transformers Ltd
- Alphalogic Techsys Ltd
- B2B Software Technologies Ltd
- Bajaj Consumer Care Ltd
- Biofil Chemicals & Pharmaceuticals Ltd
- Biogen Pharmachem Industries Ltd
- Caspian Corporate Service [list continues]
Stage II:
- Antelopus Selan Energy Ltd
Regulatory Changes
No changes to the ST-ASM framework structure itself. The circular implements routine surveillance adjustments by adding and removing securities based on their trading patterns and risk profiles.
Compliance Requirements
- Trading members must comply with ST-ASM requirements for all listed securities
- Securities marked with @ are SME scrips under ST-ASM framework
- Securities marked with * are as per NSE classification
- Securities marked with ~ are T+0 scrips shortlisted as per parent company
- Different markers indicate reason for exit: LT-ASM (*), Trade for Trade (**), GSM (#), Pledge Framework (^), or ESM ($)
Important Dates
- Effective Date: February 04, 2026
- Circular Issue Date: February 03, 2026
Impact Assessment
Market Impact: Medium - affects 17 securities with changes in surveillance framework, potentially impacting liquidity and trading patterns for these securities.
Operational Impact: Trading members dealing in these securities need to adjust their surveillance compliance measures. Securities entering ST-ASM may face additional margin requirements and trading restrictions under Stage I or Stage II measures.
Investor Impact: Investors holding or trading these securities should be aware of enhanced surveillance measures which may include price bands, margin increases, or trading frequency restrictions depending on the ASM stage.
Impact Justification
Affects trading surveillance measures for 17 securities across main board and SME segments, with operational impact on market participants trading these securities